← Open Payments lookup

NICOLE ANTAO: Open Payments

NPI 1942450986 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,145 in 106 payments from 20 companies in 2025. Trend: 2023 $444 · 2024 $819 · 2025 $2,145

Food & beverage: $2,142Education: $3
CompanyPaymentsAmount
GlaxoSmithKline, LLC.19$339
GENZYME CORPORATION12$272
AstraZeneca Pharmaceuticals LP12$232
Takeda Pharmaceuticals U.S.A., Inc.9$207
Insmed, Inc.8$151
Regeneron Healthcare Solutions, Inc.7$140
Grifols USA, LLC6$121
Viatris Specialty LLC6$100
ABBVIE INC.3$94
Boehringer Ingelheim Pharmaceuticals, Inc.3$86

Products named: DUPIXENT, NUCALA, GLASSIA, TEZSPIRE, Arikayce, Prolastin-C Liquid, YUPELRI, TRELEGY ELLIPTA.

Industry payments across IN — which companies pay providers there.